Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.nebraska.edu

Clinical Trials

Effects of Selective Laser Trabeculoplasty on Aqueous Humor Dynamics

Completed

Conditions: Open Angle Glaucoma

First Posted Date: 2011-04-27

Last Posted Date: 2023-09-06

Lead Sponsor: University of Nebraska

Target Recruit Count: 31

Registration Number: NCT01342406

Locations: 🇺🇸
University of Nebraska Medical Center, Department of Ophthalmology, Omaha, Nebraska, United States

A Multi-strain Synbiotic Versus a Multi-strain Probiotic in Premature Infants

Not Applicable

Withdrawn

Conditions: Feeding; Difficult, Newborn
Necrotizing Enterocolitis

Interventions: Dietary Supplement: Multi-strain Probiotic

First Posted Date: 2011-04-19

Last Posted Date: 2023-08-14

Lead Sponsor: University of Nebraska

Registration Number: NCT01337921

Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

Phase 1

Completed

Conditions: Peripheral T-cell Lymphoma
Adult Nasal Type Extranodal NK/T-cell Lymphoma
Anaplastic Large Cell Lymphoma
Angioimmunoblastic T-cell Lymphoma
Recurrent Adult T-cell Leukemia/Lymphoma

Interventions: Drug: carfilzomib

First Posted Date: 2011-04-18

Last Posted Date: 2023-09-15

Lead Sponsor: University of Nebraska

Target Recruit Count: 15

Registration Number: NCT01336920

Locations: 🇺🇸
Emory University, Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States
🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

Phase 2

Completed

Conditions: Anaplastic Large Cell Lymphoma
Hepatosplenic T-cell Lymphoma
Angioimmunoblastic T-cell Lymphoma
Peripheral T-cell Lymphoma

Interventions: Drug: prednisone
Drug: cyclophosphamide
Drug: etoposide
Drug: Vincristine
Drug: pralatrexate
Other: laboratory biomarker analysis
Genetic: comparative genomic hybridization
Genetic: gene expression analysis
Genetic: nucleic acid sequencing
Genetic: mutation analysis
Other: immunohistochemistry staining method
Genetic: microarray analysis
Genetic: RNA analysis

First Posted Date: 2011-04-18

Last Posted Date: 2023-09-22

Lead Sponsor: University of Nebraska

Target Recruit Count: 34

Registration Number: NCT01336933

Locations: 🇺🇸
Mayo Clinic, Arizona, Scottsdale, Arizona, United States
🇺🇸
Stanford University, Stanford, California, United States
🇺🇸
Emory University School Of Medicine, Atlanta, Georgia, United States

and more 6 locations

Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer

Phase 2

Terminated

Conditions: Adenocarcinoma of the Gastroesophageal Junction
Esophageal Adenocarcinoma
Stage IIA Esophageal Cancer
Stage IIB Esophageal Cancer

Interventions: Drug: Fluorouracil
Other: Laboratory Biomarker Analysis
Drug: Leucovorin Calcium
Drug: Oxaliplatin
Biological: Panitumumab
Other: Pharmacological Study
Radiation: Radiation Therapy
Procedure: Therapeutic Conventional Surgery

First Posted Date: 2011-03-03

Last Posted Date: 2023-10-26

Lead Sponsor: University of Nebraska

Target Recruit Count: 11

Registration Number: NCT01307956

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Web-Based Weight Loss & Weight Maintenance Intervention for Older Rural Women, Also Known as Women Weigh-in for Wellness

Not Applicable

Completed

Conditions: Overweight and Obesity

First Posted Date: 2011-03-03

Last Posted Date: 2023-09-06

Lead Sponsor: University of Nebraska

Target Recruit Count: 301

Registration Number: NCT01307644

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Impact of a High-fat Meal on Assessment of Clopidogrel-induced Platelet Inhibition in Healthy Subjects

Not Applicable

Completed

Conditions: Healthy

Interventions: Other: high fat meal

First Posted Date: 2011-03-03

Last Posted Date: 2023-09-01

Lead Sponsor: University of Nebraska

Target Recruit Count: 12

Registration Number: NCT01307657

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Aqueous Humor Dynamics and Biometric Parameters in Eyes of Children

Completed

Conditions: Healthy

First Posted Date: 2011-02-07

Last Posted Date: 2023-09-29

Lead Sponsor: University of Nebraska

Target Recruit Count: 53

Registration Number: NCT01290588

Locations: 🇺🇸
University of Nebraska Medical Center, Department of Ophthalmology and Visual Sciences, Omaha, Nebraska, United States

IOP Lowering Effects of Topical Anesthetics Used Frequently in the Ophthalmology Clinic

Completed

Conditions: Normal Tension Glaucoma

First Posted Date: 2010-12-06

Last Posted Date: 2023-09-01

Lead Sponsor: University of Nebraska

Target Recruit Count: 43

Registration Number: NCT01254149

Locations: 🇺🇸
University of Nebraska Medical Center, Department of Ophthalmology, Omaha, Nebraska, United States

Comparison of Traditional and Echocardiography Guided Fluid Management During Cytoreductive Surgery With HIPEC

Not Applicable

Withdrawn

Conditions: Echocardiography Guided Fluid Management
Peritoneal Neoplasms

Interventions: Device: Echocardiogram

First Posted Date: 2010-10-21

Last Posted Date: 2023-08-14

Lead Sponsor: University of Nebraska

Registration Number: NCT01225757

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy